{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:39:21Z","timestamp":1788172761142,"version":"build-2803163510"},"reference-count":101,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Due to higher survival rates with good quality of life, related to new treatments in the fields of oncology, hematology, and transplantation, the number of immunocompromised patients is increasing. But these patients are at high risk of intensive care unit admission because of numerous complications. Acute respiratory failure due to severe community-acquired pneumonia is one of the leading causes of admission. In this setting, the need for invasive mechanical ventilation is up to 60%, associated with a high hospital mortality rate of around 40 to 50%. A wide range of pathogens according to the reason of immunosuppression is associated with severe pneumonia in those patients: documented bacterial pneumonia represents a third of cases, viral and fungal pneumonia both account for up to 15% of cases. For patients with an undetermined etiology despite comprehensive diagnostic workup, the hospital mortality rate is very high. Thus, a standardized diagnosis strategy should be defined to increase the diagnosis rate and prescribe the appropriate treatment. This review focuses on the benefit-to-risk ratio of invasive or noninvasive strategies, in the era of omics, for the management of critically ill immunocompromised patients with severe pneumonia in terms of diagnosis and oxygenation.<\/jats:p>","DOI":"10.1055\/s-0043-1778137","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:16:15Z","timestamp":1706141775000},"page":"255-265","source":"Crossref","is-referenced-by-count":9,"title":["Severe Community-Acquired Pneumonia in Immunocompromised Patients"],"prefix":"10.1055","volume":"45","author":[{"given":"Dara","family":"Chean","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, AP-HP Saint-Louis University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Windsor","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, AP-HP Henri Mondor University Hospital, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Lafarge","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, AP-HP Saint-Louis University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Dupont","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, AP-HP Saint-Louis University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrine","family":"Nakaa","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, AP-HP Saint-Louis University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Whiting","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, AP-HP Saint-Louis University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Joseph","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, AP-HP Saint-Louis University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Lemiale","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, AP-HP Saint-Louis University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[{"name":"Medical Intensive Care Unit, AP-HP Saint-Louis University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"issue":"23","key":"ref1","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1001\/jama.2016.16477","article-title":"Prevalence of immunosuppression among US adults, 2013","volume":"316","author":"R Harpaz","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1158\/0008-5472.CAN-09-0547","article-title":"Bispecific T-cell engaging antibodies for cancer therapy","volume":"69","author":"P A Baeuerle","year":"2009","journal-title":"Cancer Res"},{"issue":"03","key":"ref3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41568-020-00323-z","article-title":"Recent advances and discoveries in the mechanisms and functions of CAR T cells","volume":"21","author":"R C Larson","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s00134-014-3433-2","article-title":"Has survival increased in cancer patients admitted to the ICU? Yes","volume":"40","author":"D Mokart","year":"2014","journal-title":"Intensive Care Med"},{"issue":"07","key":"ref5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00134-019-05653-7","article-title":"Changes in critically ill cancer patients' short-term outcome over the last decades: results of systematic review with meta-analysis on individual data","volume":"45","author":"M Darmon","year":"2019","journal-title":"Intensive Care Med"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00134-020-06184-2","article-title":"Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study","volume":"47","author":"F G Zampieri","year":"2021","journal-title":"Intensive Care Med"},{"issue":"07","key":"ref7","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3109\/10428194.2011.649752","article-title":"Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure","volume":"53","author":"E Lenglin\u00e9","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"08","key":"ref8","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3109\/10428194.2012.753446","article-title":"Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure","volume":"54","author":"D Mokart","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"22","key":"ref9","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","article-title":"Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium\u2014a groupe de recherche respiratoire en r\u00e9animation onco-h\u00e9matologique study","volume":"31","author":"E Azoulay","year":"2013","journal-title":"J Clin Oncol"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1164\/rccm.201212-2169OC","article-title":"Evolution of mortality over time in patients receiving mechanical ventilation","volume":"188","author":"A Esteban","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1164\/rccm.202009-3575OC","article-title":"Survival in immunocompromised patients ultimately requiring invasive mechanical ventilation: a pooled individual patient data analysis","volume":"204","author":"G Dumas","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00134-019-05906-5","article-title":"Diagnosis of severe respiratory infections in immunocompromised patients","volume":"46","author":"E Azoulay","year":"2020","journal-title":"Intensive Care Med"},{"issue":"09","key":"ref13","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/cid\/ciy723","article-title":"Prevalence and etiology of community-acquired pneumonia in immunocompromised patients","volume":"68","author":"M F Di Pasquale","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1469-0691.2012.03765.x","article-title":"Community-acquired pneumonia in immunocompromised older patients: incidence, causative organisms and outcome","volume":"19","author":"D Sousa","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00134-017-4947-1","article-title":"Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study","volume":"43","author":"E Azoulay","year":"2017","journal-title":"Intensive Care Med"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13613-016-0202-0","article-title":"Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en R\u00e9animation Respiratoire en Onco-H\u00e9matologique (Grrr-OH) study","volume":"6","author":"A Contejean","year":"2016","journal-title":"Ann Intensive Care"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.3109\/10428194.2014.887709","article-title":"Respiratory events at the earliest phase of acute myeloid leukemia","volume":"55","author":"A-S Moreau","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"1802442","DOI":"10.1183\/13993003.02442-2018","article-title":"Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy","volume":"54","author":"P R Bauer","year":"2019","journal-title":"Eur Respir J"},{"issue":"08","key":"ref19","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1164\/rccm.201001-0018OC","article-title":"Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial","volume":"182","author":"E Azoulay","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"06","key":"ref20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00134-006-0129-2","article-title":"Diagnostic strategy in cancer patients with acute respiratory failure","volume":"32","author":"E Azoulay","year":"2006","journal-title":"Intensive Care Med"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00134-019-05896-4","article-title":"Benefit-to-risk balance of bronchoalveolar lavage in the critically ill. A prospective, multicenter cohort study","volume":"46","author":"T Kamel","year":"2020","journal-title":"Intensive Care Med"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1164\/rccm.201804-0681OC","article-title":"Clinical significance of upper airway virus detection in critically ill hematology patients","volume":"199","author":"J Legoff","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-2600(18)30345-X","article-title":"Acute respiratory failure in immunocompromised adults","volume":"7","author":"E Azoulay","year":"2019","journal-title":"Lancet Respir Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2685723","DOI":"10.1155\/2018\/2685723","article-title":"Comparison of respiratory pathogen detection in upper versus lower respiratory tract samples using the BioFire FilmArray respiratory panel in the immunocompromised host","volume":"2018","author":"N Azadeh","year":"2018","journal-title":"Can Respir J"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.chest.2018.06.018","article-title":"Multiplex PCR on the bronchoalveolar lavage fluid of immunocompromised patients","volume":"154","author":"K Affolter","year":"2018","journal-title":"Chest"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.chest.2020.11.008","article-title":"Added diagnostic utility of clinical metagenomics for the diagnosis of pneumonia in immunocompromised adults","volume":"159","author":"M M Azar","year":"2021","journal-title":"Chest"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/cid\/ciab043","article-title":"Validation of a host gene expression test for bacterial\/viral discrimination in immunocompromised hosts","volume":"73","author":"R E Mahle","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"07","key":"ref28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200102153440703","article-title":"Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure","volume":"344","author":"G Hilbert","year":"2001","journal-title":"N Engl J Med"},{"issue":"02","key":"ref29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.283.2.235","article-title":"Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial","volume":"283","author":"M Antonelli","year":"2000","journal-title":"JAMA"},{"issue":"08","key":"ref30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2213-2600(16)30093-5","article-title":"Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial","volume":"4","author":"J-P Frat","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"16","key":"ref31","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2015.12402","article-title":"Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial","volume":"314","author":"V Lemiale","year":"2015","journal-title":"JAMA"},{"issue":"03","key":"ref32","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1097\/CCM.0000000000002085","article-title":"High-flow nasal cannula oxygenation in immunocompromised patients with acute hypoxemic respiratory failure: a Groupe de Recherche Respiratoire en R\u00e9animation Onco-H\u00e9matologique Study","volume":"45","author":"V Lemiale","year":"2017","journal-title":"Crit Care Med"},{"issue":"20","key":"ref33","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2018.14282","article-title":"Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial","volume":"320","author":"E Azoulay","year":"2018","journal-title":"JAMA"},{"issue":"07","key":"ref34","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S2213-2600(22)00096-0","article-title":"High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial","volume":"10","author":"R Coudroy","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3390\/medicina55100693","article-title":"The impact of high-flow nasal cannula on the outcome of immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis","volume":"55","author":"L-C Cheng","year":"2019","journal-title":"Medicina (Kaunas)"},{"issue":"03","key":"ref36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jemermed.2020.01.016","article-title":"Use of high-flow nasal cannula for immunocompromise and acute respiratory failure: a systematic review and meta-analysis","volume":"58","author":"Y Wang","year":"2020","journal-title":"J Emerg Med"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2020.9524","article-title":"Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure: a systematic review and meta-analysis","volume":"324","author":"B L Ferreyro","year":"2020","journal-title":"JAMA"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00134-011-2375-1","article-title":"Fiberoptic bronchoscopy under noninvasive ventilation and propofol target-controlled infusion in hypoxemic patients","volume":"37","author":"B Clouzeau","year":"2011","journal-title":"Intensive Care Med"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1378\/chest.110.3.724","article-title":"Noninvasive positive-pressure ventilation via face mask during bronchoscopy with BAL in high-risk hypoxemic patients","volume":"110","author":"M Antonelli","year":"1996","journal-title":"Chest"},{"issue":"06","key":"ref40","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1186\/s13054-014-0712-9","article-title":"High-flow nasal cannula oxygen versus non-invasive ventilation in patients with acute hypoxaemic respiratory failure undergoing flexible bronchoscopy\u2014a prospective randomised trial","volume":"18","author":"M Simon","year":"2014","journal-title":"Crit Care"},{"issue":"02","key":"ref41","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.115.2.462","article-title":"Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients","volume":"115","author":"M H Kollef","year":"1999","journal-title":"Chest"},{"issue":"06","key":"ref42","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/thoraxjnl-2015-207513","article-title":"Time to first antibiotic and mortality in adults hospitalised with community-acquired pneumonia: a matched-propensity analysis","volume":"71","author":"P Daniel","year":"2016","journal-title":"Thorax"},{"issue":"02","key":"ref43","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00134-022-06954-0","article-title":"Relationship between immunosuppression and intensive care unit-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter cohort study","volume":"49","author":"L Kreitmann","year":"2023","journal-title":"Intensive Care Med"},{"issue":"08","key":"ref44","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/rccm.201301-0079OC","article-title":"Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia","volume":"188","author":"Y Shindo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"05","key":"ref45","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","article-title":"Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies","volume":"158","author":"J A Ramirez","year":"2020","journal-title":"Chest"},{"issue":"07","key":"ref46","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"J P Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1513\/AnnalsATS.201407-305OC","article-title":"Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia","author":"E Prina","year":"2015","journal-title":"Ann Am Thorac Soc 12"},{"issue":"07","key":"ref48","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/ciy631","article-title":"A therapeutic strategy for all pneumonia patients: a 3-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy","volume":"68","author":"T Maruyama","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s13054-020-03114-y","article-title":"Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia","volume":"24","author":"C Monard","year":"2020","journal-title":"Crit Care"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41598-021-03741-7","article-title":"Rapid syndromic PCR testing in patients with respiratory tract infections reduces time to results and improves microbial yield","volume":"12","author":"S Serigstad","year":"2022","journal-title":"Sci Rep"},{"issue":"07","key":"ref51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/civ1214","article-title":"Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia","volume":"62","author":"N J Gadsby","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref52","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1164\/rccm.201712-2452OC","article-title":"A multivariable prediction model for Pneumocystis jirovecii pneumonia in hematology patients with acute respiratory failure","volume":"198","author":"E Azoulay","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"24","key":"ref53","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"C F Thomas Jr","year":"2004","journal-title":"N Engl J Med"},{"issue":"06","key":"ref54","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"R Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"issue":"12","key":"ref55","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"A Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"ref56","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"O A Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"ref57","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"Prospective pilot study of high-dose (10\u2009mg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis","volume":"70","author":"F Lanternier","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"07","key":"ref58","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"F M Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"05","key":"ref59","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/427801","article-title":"Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture","volume":"40","author":"M GJ van Kraaij","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref60","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/cid\/ciz638","article-title":"Outcomes of immunocompromised adults hospitalized with laboratory-confirmed influenza in the United States, 2011-2015","volume":"70","author":"J P Collins","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref61","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-2007-976494","article-title":"Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection","volume":"28","author":"Y-J Kim","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"issue":"03","key":"ref62","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1086\/525263","article-title":"Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature","volume":"46","author":"N Khanna","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"08","key":"ref63","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.rmed.2012.05.001","article-title":"Molecular detection of respiratory viruses in immunocopromised ICU patients: incidence and meaning","volume":"106","author":"D Schnell","year":"2012","journal-title":"Respir Med"},{"issue":"9979","key":"ref64","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","article-title":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials","volume":"385","author":"J Dobson","year":"2015","journal-title":"Lancet"},{"issue":"03","key":"ref65","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/clinids\/22.3.537","article-title":"Cytomegalovirus infection following liver transplantation: review of the literature","volume":"22","author":"S S Kanj","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"03","key":"ref66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1399-3062.2009.00372.x","article-title":"Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation","volume":"11","author":"R A Fisher","year":"2009","journal-title":"Transpl Infect Dis"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1399-3062.2003.00023.x","article-title":"Pulmonary involvement during cytomegalovirus infection in immunosuppressed patients","volume":"5","author":"E F de Maar","year":"2003","journal-title":"Transpl Infect Dis"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"P Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"03","key":"ref69","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1378\/chest.119.3.838","article-title":"Pulmonary cytomegalovirus infection in immunocompromised patients","volume":"119","author":"M Tamm","year":"2001","journal-title":"Chest"},{"issue":"06","key":"ref70","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"C N Kotton","year":"2018","journal-title":"Transplantation"},{"issue":"07","key":"ref71","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive agents and infectious risk in transplantation: managing the \u201cnet state of immunosuppression\u201d","volume":"73","author":"M B Roberts","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"08","key":"ref72","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/j.1600-6143.2010.03114.x","article-title":"Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients","volume":"10","author":"A Asberg","year":"2010","journal-title":"Am J Transplant"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/j.ijid.2010.09.006","article-title":"Cryptococcal immune reconstitution syndrome during steroid withdrawal treated with hydroxychloroquine","volume":"15","author":"S Narayanan","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"10","key":"ref74","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1086\/592690","article-title":"Cryptococcosis in solid organ transplant recipients: current state of the science","volume":"47","author":"N Singh","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"20","key":"ref75","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa1800762","article-title":"Prednisone for the prevention of paradoxical tuberculosis-associated IRIS","volume":"379","author":"G Meintjes","year":"2018","journal-title":"N Engl J Med"},{"issue":"04","key":"ref76","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/tid.12249","article-title":"Severe infections requiring intensive care unit admission in kidney transplant recipients: impact on graft outcome","volume":"16","author":"N Bige","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"06","key":"ref77","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1034\/j.1399-0012.2002.02079.x","article-title":"A standardized protocol for the treatment of severe pneumonia in kidney transplant recipients","volume":"16","author":"P Sileri","year":"2002","journal-title":"Clin Transplant"},{"issue":"02","key":"ref78","doi-asserted-by":"crossref","first-page":"e55870","DOI":"10.1371\/journal.pone.0055870","article-title":"Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival","volume":"8","author":"E Canet","year":"2013","journal-title":"PLoS One"},{"issue":"04","key":"ref79","doi-asserted-by":"crossref","first-page":"344","DOI":"10.6002\/ect.2012.0015","article-title":"Aggressive immunosuppressant reduction and long-term rejection risk in renal transplant recipients with Pneumocystis jiroveci pneumonia","volume":"10","author":"C-Y Yang","year":"2012","journal-title":"Exp Clin Transplant"},{"issue":"07","key":"ref80","doi-asserted-by":"crossref","first-page":"372","DOI":"10.11622\/smedj.2014089","article-title":"Immunosuppressant dose reduction and long-term rejection risk in renal transplant recipients with severe bacterial pneumonia","volume":"55","author":"C J Shih","year":"2014","journal-title":"Singapore Med J"},{"issue":"04","key":"ref81","doi-asserted-by":"crossref","first-page":"e14221","DOI":"10.1111\/ctr.14221","article-title":"Influence of patient characteristics and immunosuppressant management on mortality in kidney transplant recipients hospitalized with coronavirus disease 2019 (COVID-19)","volume":"35","author":"A D Santeusanio","year":"2021","journal-title":"Clin Transplant"},{"issue":"21","key":"ref82","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"P-F Dequin","year":"2023","journal-title":"N Engl J Med"},{"issue":"05","key":"ref83","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1378\/chest.113.5.1215","article-title":"Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia","volume":"113","author":"J G Pareja","year":"1998","journal-title":"Chest"},{"issue":"10","key":"ref84","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1128\/AAC.00669-11","article-title":"Outcomes of moderate-to-severe Pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients","volume":"55","author":"S M Moon","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"03","key":"ref85","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.chest.2018.04.026","article-title":"Early corticosteroids for Pneumocystis pneumonia in adults without HIV are not associated with better outcome","volume":"154","author":"P M Wieruszewski","year":"2018","journal-title":"Chest"},{"issue":"01","key":"ref86","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1465-9921-14-87","article-title":"Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia","volume":"14","author":"V Lemiale","year":"2013","journal-title":"Respir Res"},{"issue":"03","key":"ref87","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bmt.1705037","article-title":"Respiratory status deterioration during G-CSF-induced neutropenia recovery","volume":"36","author":"L Karlin","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"01","key":"ref88","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/cc8198","article-title":"Acute respiratory distress syndrome during neutropenia recovery","volume":"14","author":"E Azoulay","year":"2010","journal-title":"Crit Care"},{"issue":"05","key":"ref89","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1080\/10428194.2018.1516874","article-title":"Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignancies","volume":"60","author":"X Mignard","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"05","key":"ref90","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/thorax.56.5.379","article-title":"Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures","volume":"56","author":"A Ra\u00f1\u00f3","year":"2001","journal-title":"Thorax"},{"issue":"06","key":"ref91","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1128\/JCM.40.6.2134-2140.2002","article-title":"Pulmonary infiltrates in immunosuppressed patients: analysis of a diagnostic protocol","volume":"40","author":"C Dan\u00e9s","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"01","key":"ref92","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/01.CCM.0000295590.33145.C4","article-title":"Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data","volume":"36","author":"E Azoulay","year":"2008","journal-title":"Crit Care Med"},{"issue":"01","key":"ref93","doi-asserted-by":"crossref","first-page":"e2020025","DOI":"10.4084\/mjhid.2020.025","article-title":"Clinical usefulness of bronchoalveolar lavage in the management of pulmonary infiltrates in adults with hematological malignancies and stem cell transplantation","volume":"12","author":"L Jorge","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"09","key":"ref94","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cmi.2020.05.024","article-title":"Diagnostic accuracy of serum (1-3)-\u03b2-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis","volume":"26","author":"O Del Corpo","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"01","key":"ref95","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cmi.2021.08.017","article-title":"Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis","volume":"28","author":"J Sen\u00e9cal","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"09","key":"ref96","doi-asserted-by":"crossref","first-page":"e73099","DOI":"10.1371\/journal.pone.0073099","article-title":"Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: a bivariate meta-analysis and systematic review","volume":"8","author":"L-C Fan","year":"2013","journal-title":"PLoS One"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"J A Maertens","year":"2016","journal-title":"Lancet"},{"issue":"06","key":"ref98","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1128\/JCM.00467-14","article-title":"Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis","volume":"52","author":"M Hoenigl","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"08","key":"ref99","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/cid\/civ507","article-title":"Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing","volume":"61","author":"P L White","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"05","key":"ref100","first-page":"CD012399","article-title":"Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients","volume":"5","author":"K de Heer","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"ref101","first-page":"CD007394","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"2015","author":"M MG Leeflang","year":"2015","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1778137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:57:42Z","timestamp":1730804262000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1778137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":101,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2024,4,11]]},"published-print":{"date-parts":[[2024,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1778137","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]}}}